Abstract
BackgroundSpatial architecture within the tumor microenvironment (TME) can potentially impact disease pathology, progression and treatment response of DLBCL. Additionally, activation of host’s immune system greatly determines response to immunotherapy treatments....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have